AlzChem Group AG
DUS:ACT

Watchlist Manager
AlzChem Group AG Logo
AlzChem Group AG
DUS:ACT
Watchlist
Price: 161.4 EUR -1.41% Market Closed
Market Cap: €1.6B

Wall St Price Targets

ACT Price Targets Summary
AlzChem Group AG

Wall Street analysts forecast ACT stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACT is 208.14 EUR with a low forecast of 177.24 EUR and a high forecast of 266.51 EUR.

Lowest Forecast
Price Target
177.24 EUR
10% Upside
Average Forecast
Price Target
208.14 EUR
29% Upside
Highest Forecast
Price Target
266.51 EUR
65% Upside
AlzChem Group AG Competitors:
Price Targets
89W
Ecoener SA
78% Upside
CELL
Cellularline SpA
59% Upside
BLK
BlackRock Inc
19% Upside
GATX
GATX Corp
27% Upside

Revenue
Forecast

7% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss
7% / Year
Past Growth
9% / Year
Estimated Growth
Estimates Accuracy
0%
Average Miss

Over the last 6 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 8 years is 9%.

Gross Profit
Forecast

9% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat
9% / Year
Past Growth
12% / Year
Estimated Growth
Estimates Accuracy
0%
Average Beat

Over the last 6 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 3 years is 12%.

Operating Income
Forecast

21% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat
21% / Year
Past Growth
13% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat

Over the last 6 years, the compound annual growth rate for Operating Income has been 21%. The projected CAGR for the next 8 years is 13%.

Pre-Tax Income
Forecast

23% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat
23% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat

Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been 23%. The projected CAGR for the next 3 years is 20%.

Net Income
Forecast

23% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat
23% / Year
Past Growth
20% / Year
Estimated Growth
Estimates Accuracy
4%
Average Beat

Over the last 6 years, the compound annual growth rate for Net Income has been 23%. The projected CAGR for the next 3 years is 20%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is ACT's stock price target?
Price Target
208.14 EUR

According to Wall Street analysts, the average 1-year price target for ACT is 208.14 EUR with a low forecast of 177.24 EUR and a high forecast of 266.51 EUR.

What is the Revenue forecast for AlzChem Group AG?
Projected CAGR
9%

Over the last 6 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 8 years is 9%.

What is the Gross Profit forecast for AlzChem Group AG?
Projected CAGR
12%

Over the last 6 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 3 years is 12%.

What is the Operating Income forecast for AlzChem Group AG?
Projected CAGR
13%

Over the last 6 years, the compound annual growth rate for Operating Income has been 21%. The projected CAGR for the next 8 years is 13%.

What is the Pre-Tax Income forecast for AlzChem Group AG?
Projected CAGR
20%

Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been 23%. The projected CAGR for the next 3 years is 20%.

What is the Net Income forecast for AlzChem Group AG?
Projected CAGR
20%

Over the last 6 years, the compound annual growth rate for Net Income has been 23%. The projected CAGR for the next 3 years is 20%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett